Published in Arch Microbiol on April 01, 1985
Bacteriocins of gram-positive bacteria. Microbiol Rev (1995) 7.68
A new antibiotic kills pathogens without detectable resistance. Nature (2015) 6.33
Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob Agents Chemother (2000) 3.06
Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol Mol Biol Rev (1998) 2.37
Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol (1987) 1.82
In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother (1999) 1.77
Wall teichoic acids of gram-positive bacteria. Annu Rev Microbiol (2013) 1.77
Autolysis of Lactococcus lactis is increased upon D-alanine depletion of peptidoglycan and lipoteichoic acids. J Bacteriol (2005) 1.49
Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob Agents Chemother (2006) 1.36
Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells. J Virol (2005) 1.23
Structural basis of cell wall cleavage by a staphylococcal autolysin. PLoS Pathog (2010) 1.20
Atomic force microscopy study of the effect of antimicrobial peptides on the cell envelope of Escherichia coli. Antimicrob Agents Chemother (2005) 1.18
Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG. Appl Environ Microbiol (2007) 1.17
Novel mechanism for nisin resistance via proteolytic degradation of nisin by the nisin resistance protein NSR. Antimicrob Agents Chemother (2009) 1.17
Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepI and localization and functional analysis of its gene product. Appl Environ Microbiol (1994) 1.14
Role of transmembrane pH gradient and membrane binding in nisin pore formation. J Bacteriol (1997) 1.11
Bactericidal mode of action of plantaricin C. Appl Environ Microbiol (1996) 1.04
Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl Environ Microbiol (2006) 1.01
Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS One (2012) 1.01
Effect of peptide AS-48 on Enterococcus faecalis subsp. liquefaciens S-47. Antimicrob Agents Chemother (1989) 0.99
Staphylococcin 1580 is identical to the lantibiotic epidermin: implications for the nature of bacteriocins from gram-positive bacteria. Appl Environ Microbiol (1994) 0.96
Human beta-defensin-2: a natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity. J Matern Fetal Neonatal Med (2007) 0.96
Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria. Antimicrob Agents Chemother (2004) 0.96
Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters. PLoS One (2016) 0.93
Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5. Antimicrob Agents Chemother (2011) 0.91
Reduced lysis upon growth of Lactococcus lactis on galactose is a consequence of decreased binding of the autolysin AcmA. Appl Environ Microbiol (2008) 0.89
Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus. Appl Environ Microbiol (2002) 0.87
Antimicrobial activities of squalamine mimics. Antimicrob Agents Chemother (1997) 0.86
Antibacterial activities of nisin Z encapsulated in liposomes or produced in situ by mixed culture during cheddar cheese ripening. Appl Environ Microbiol (2002) 0.83
Phospholipid synthesis by Staphylococcus aureus during (Sub)Lethal attack by mammalian 14-kilodalton group IIA phospholipase A2. Infect Immun (2000) 0.82
The Cyclic Antibacterial Peptide Enterocin AS-48: Isolation, Mode of Action, and Possible Food Applications. Int J Mol Sci (2014) 0.82
Killing of staphylococci by θ-defensins involves membrane impairment and activation of autolytic enzymes. Antibiotics (Basel) (2014) 0.80
Antimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of Bacteria. Front Cell Dev Biol (2016) 0.77
Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules? Front Immunol (2012) 0.77
Antimicrobial nisin acts against saliva derived multi-species biofilms without cytotoxicity to human oral cells. Front Microbiol (2015) 0.76
β-defensins: An innate defense for bovine mastitis. Vet World (2017) 0.75
Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science (1999) 5.30
Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob Agents Chemother (1985) 3.83
Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem (2000) 3.65
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol (2009) 3.45
Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu Rev Microbiol (1998) 3.04
Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol (1998) 2.69
Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. Eur J Biochem (1995) 2.37
Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis. J Gen Microbiol (1981) 2.20
Mode of action of the staphylococcinlike peptide Pep 5: voltage-dependent depolarization of bacterial and artificial membranes. J Bacteriol (1988) 2.10
Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry (1995) 2.10
The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob Agents Chemother (1998) 2.06
Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes. FEBS Lett (1989) 1.95
Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J Clin Microbiol Infect Dis (1999) 1.87
Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol (1989) 1.85
Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase. J Bacteriol (1987) 1.82
Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster. Appl Environ Microbiol (2000) 1.81
Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun (1996) 1.79
Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol Microbiol (1996) 1.71
Influence of the staphylococcinlike peptide Pep 5 on membrane potential of bacterial cells and cytoplasmic membrane vesicles. J Bacteriol (1985) 1.71
The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur J Biochem (1997) 1.59
Mode of action of the staphylococcin-like peptide Pep 5 and culture conditions effecting its activity. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 1.58
Protein engineering of lantibiotics. Antonie Van Leeuwenhoek (1996) 1.54
The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes. Eur J Biochem (1989) 1.54
Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob Agents Chemother (1995) 1.52
Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. Eur J Biochem (1995) 1.50
Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin. Antimicrob Agents Chemother (1985) 1.48
Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem (1990) 1.40
Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol (1998) 1.29
Extensive post-translational modification, including serine to D-alanine conversion, in the two-component lantibiotic, lacticin 3147. J Biol Chem (1999) 1.29
Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol (1998) 1.28
Posttranslationally modified bacteriocins--the lantibiotics. Biopolymers (2000) 1.27
Immunity to lantibiotics. Antonie Van Leeuwenhoek (1996) 1.24
Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5. Appl Environ Microbiol (1996) 1.18
Construction of an expression system for engineering of the lantibiotic Pep5. Appl Environ Microbiol (1994) 1.16
Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol Lett (1995) 1.15
Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin. J Bacteriol (1992) 1.14
Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22. Eur J Biochem (1994) 1.14
Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepI and localization and functional analysis of its gene product. Appl Environ Microbiol (1994) 1.14
Interaction of the staphylococcin-like peptide Pep 5 with cell walls and isolated cell wall components of Gram-positive bacteria. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 1.10
Plasmid involvement in production of and immunity to the staphylococcin-like peptide Pep 5. J Gen Microbiol (1984) 1.07
Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria. Zentralbl Bakteriol (1993) 1.05
Identification and analysis of a gene encoding a Fur-like protein of Staphylococcus epidermidis. FEMS Microbiol Lett (1996) 1.03
New insights into the mechanism of action of lantibiotics--diverse biological effects by binding to the same molecular target. J Antimicrob Chemother (2000) 1.02
Molecular analysis of expression of the lantibiotic pep5 immunity phenotype. Appl Environ Microbiol (1999) 1.02
Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. Eur J Biochem (1995) 1.02
The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7. Antonie Van Leeuwenhoek (1996) 1.00
The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur J Biochem (1994) 0.96
Typing and antimicrobial susceptibilities of methicillin resistant Staphylococcus aureus (MRSA) strains isolated in a hospital in Korea. J Korean Med Sci (2001) 0.95
Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect Immun (1999) 0.95
Human-associated Staphylococcus aureus strains within great ape populations in Central Africa (Gabon). Clin Microbiol Infect (2013) 0.93
Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate. FEMS Microbiol Lett (1992) 0.91
Mechanism of action and limited cross-resistance of new lipopeptide MX-2401. Antimicrob Agents Chemother (2011) 0.90
Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Eur J Biochem (1995) 0.90
Molecular characterisation of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus. J Mol Biol (2001) 0.89
Purification and partial characterization of a murein hydrolase, millericin B, produced by Streptococcus milleri NMSCC 061. Appl Environ Microbiol (2000) 0.88
Effects of the lantibiotic mersacidin on the morphology of staphylococci. Zentralbl Bakteriol (1996) 0.87
Malic enzyme of chromatium vinosum. Arch Microbiol (1980) 0.86
Successful management of an MRSA outbreak in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis (2011) 0.86
The genetics of lantibiotic biosynthesis. Bioessays (1995) 0.85
GIS-supported investigation of a nosocomial Salmonella outbreak. Int J Hyg Environ Health (2000) 0.85
Effect of leader peptide mutations on biosynthesis of the lantibiotic Pep5. FEMS Microbiol Lett (1997) 0.84
Isolation and mode of action of a staphylococcin-like substance active against gram-positive and gram-negative bacteria. J Gen Microbiol (1984) 0.82
Unique peptide modifications involved in the biosynthesis of lantibiotics. Trends Biotechnol (1995) 0.82
Carnocin UI49, a potential biopreservative produced by Carnobacterium piscicola: large scale purification and activity against various gram-positive bacteria including Listeria sp. Int J Food Microbiol (1993) 0.82
Influence of cationic peptides on the activity of the autolytic endo-beta-N-acetylglucosaminidase of Staphylococcus simulans 22. FEMS Microbiol Lett (1989) 0.81
Purification and properties of LIQ 4, an antibacterial substance produced by Streptococcus faecalis var. liquefaciens K4. J Gen Microbiol (1985) 0.81
Isolation of a new epidermin variant from two strains of Staphylococcus epidermidis--frequency of lantibiotic production in coagulase-negative staphylococci. Zentralbl Bakteriol (1996) 0.78
Different mechanisms of insensitivity to the staphylococcin-like peptide Pep 5. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.77
Antibacterial activities of Candida yeasts. Partial purification and characterization of the active substance of Candida guilliermondii. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.77
Lytic activities, protein profiles and morphologic characteristics of new bacteriophages isolated from canine and human Staphylococcus aureus strains. Zentralbl Veterinarmed B (1992) 0.75
[Extent of bacterial contamination is a derminant fur microvascular damage in soft tissue infection]. Langenbecks Arch Chir Suppl Kongressbd (1998) 0.75
[Infantile Campylobacter enteritis (author's transl)]. Klin Padiatr (1981) 0.75